BioCryst to Report First Quarter 2026 Financial Results on May 6

Rhea-AI Summary

BioCryst (Nasdaq: BCRX) will report its first quarter 2026 financial results on Wednesday, May 6, 2026. Management will host a conference call and webcast at 8:30 a.m. ET to discuss results and provide a corporate update.

Investors can access the live call by phone or via a webcast with replay available on the company's investor website.

News Market Reaction – BCRX

-2.38%

-2.38% Session close to close

In the Apr 15 session, BCRX declined 2.38%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement sets expectations for first quarter 2026 results on May 6, 2026, with a call at 8:...

Analysis

This announcement sets expectations for first quarter 2026 results on May 6, 2026, with a call at 8:30 a.m. ET. Historically, similar earnings date notices, such as the February 2026 update, were followed by a modest -2.8% move, indicating limited standalone impact. Investors may focus instead on prior guidance levels and recent operational milestones when assessing the upcoming report’s significance.

Key Figures

Earnings release date: May 6, 2026 Conference call time: 8:30 a.m. ET Domestic dial-in: 1-844-481-2942 +1 more

4 metrics

Earnings release date May 6, 2026 First quarter 2026 financial results reporting date

Conference call time 8:30 a.m. ET Scheduled start of Q1 2026 results call

Domestic dial-in 1-844-481-2942 U.S. access number for Q1 2026 conference call

International dial-in 1-412-317-1866 International access number for Q1 2026 conference call

Previous Earnings date Reports

1 past event · Latest: Feb 05 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 05	Earnings date notice	Neutral	-2.8%	Announced Q4 2025 results date with related conference call details.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

For prior earnings date notices, BCRX saw a modest negative move of -2.8% on the next day.

Recent Company History

Recent BCRX news featured a mix of operational and financial milestones. On Feb 26, 2026, full-year 2025 results highlighted $601.8M in ORLADEYO revenue and maintained 2026 guidance. Earlier, conference participation and new HAE data presentations supported the ORLADEYO and navenibart franchises. The prior earnings date notice on Feb 5, 2026 preceded a -2.8% move, giving context for how the market has historically reacted to scheduling announcements like today’s.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

RESEARCH TRIANGLE PARK, N.C. , April 15, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its first quarter 2026 financial results on Wednesday, May 6, 2026.

BioCryst management will host a conference call and webcast at 8:30 a.m. ET that day to discuss the financial results and provide a corporate update.

The live call may be accessed by dialing 1-844-481-2942 for domestic callers and 1-412-317-1866 for international callers. A live webcast and replay of the call will be available online in the investors section of the company website at www.biocryst.com.

About BioCryst Pharmaceuticals

BioCryst is a global biotechnology company focused on developing and commercializing medicines for hereditary angioedema (“HAE”) and other rare diseases, driven by its deep commitment to improving the lives of people living with these conditions. BioCryst has commercialized ORLADEYO® (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of potential first-in-class or best-in-class oral small-molecule and injectable protein therapeutics for a range of rare diseases. For more information, please visit www.biocryst.com or follow us on LinkedIn.

BCRXW

Contact:

Investors:
investorrelations@biocryst.com

Media:
media@biocryst.com

FAQ

When will BioCryst (BCRX) report first quarter 2026 results and what time is the call?

BioCryst will report Q1 2026 results on Wednesday, May 6, 2026 at 8:30 a.m. ET. According to the company, management will discuss the financial results and provide a corporate update during a conference call and webcast that morning.

How can investors access the BioCryst (BCRX) May 6, 2026 earnings call and webcast?

Investors can access the live call by dialing the provided domestic or international numbers or via the company's webcast. According to the company, a live webcast and replay will be available in the investors section of the company website.

Will BioCryst (BCRX) provide a replay of the May 6, 2026 conference call?

Yes, a replay will be available online after the live call. According to the company, the live webcast and replay will be posted in the investors section of the company website for later listening.

What topics will BioCryst (BCRX) management cover on the May 6, 2026 call?

Management will discuss first quarter 2026 financial results and provide a corporate update. According to the company, the call is intended to review quarterly performance and share recent corporate developments with investors.

What phone numbers should callers use to join the BioCryst (BCRX) May 6, 2026 earnings call?

Domestic callers should dial 1-844-481-2942; international callers should use 1-412-317-1866. According to the company, those numbers provide live access to the conference call at 8:30 a.m. ET on May 6, 2026.